Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery*
暂无分享,去创建一个
[1] M. Caron,et al. Thiophilic adsorption revisited. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[2] R. Appel,et al. Guidelines for the next 10 years of proteomics , 2009, Proteomics.
[3] M. Caron,et al. Usefulness of an integrated microfluidic device (HPLC-Chip-MS) to enhance confidence in protein identification by proteomics. , 2006, Rapid communications in mass spectrometry : RCM.
[4] Arul M Chinnaiyan,et al. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer. , 2006, Urologic oncology.
[5] Weiliang Qiu,et al. Development of a “reverse capture” autoantibody microarray for studies of antigen‐autoantibody profiling , 2006, Proteomics.
[6] M. Caron,et al. A proteomic approach to investigate potential biomarkers directed against membrane‐associated breast cancer proteins , 2006, Electrophoresis.
[7] A. Zlotta. Auto-Antibody Signatures in Prostate Cancer , 2006 .
[8] O. Finn,et al. Immune response as a biomarker for cancer detection and a lot more. , 2005, The New England journal of medicine.
[9] Debashis Ghosh,et al. Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.
[10] J. Bigeard,et al. Proteomic Analysis of Membrane-associated Proteins from the Breast Cancer Cell Line MCF7. , 2005, Cancer genomics & proteomics.
[11] M. Caron,et al. An efficient proteomics-based approach for the screening of autoantibodies. , 2005, Journal of immunological methods.
[12] Yiling Lu,et al. Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian Carcinoma* , 2005, Molecular & Cellular Proteomics.
[13] R. Kuick,et al. Identification of Defensin α6 as a Potential Biomarker in Colon Adenocarcinoma* , 2005, Journal of Biological Chemistry.
[14] H. Yin,et al. Microfluidic chip for peptide analysis with an integrated HPLC column, sample enrichment column, and nanoelectrospray tip. , 2005, Analytical chemistry.
[15] H. Fukuda,et al. Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. , 2004, Arthritis and rheumatism.
[16] A. Stromberg,et al. Identification of circulating antibodies to tumor‐associated proteins for combined use as markers of non‐small cell lung cancer , 2004, Proteomics.
[17] David E. Misek,et al. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. , 2004, Journal of proteome research.
[18] A. Purcell,et al. Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response. , 2004, Molecular & cellular proteomics : MCP.
[19] C. Musselli,et al. Autoimmune and Antitumor Consequences of Antibodies Against Antigens Shared by Normal and Malignant Tissues , 2000, Journal of Clinical Immunology.
[20] A. Jemal,et al. Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.
[21] D. Jäger,et al. CTL-defined Cancer Vaccines: Perspectives for Active Immunotherapeutic Interventions in Minimal Residual Disease , 2004, Cancer and Metastasis Reviews.
[22] Cecelia E Schmalbach,et al. Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin C‐terminal hydrolase L3 , 2003, Proteomics.
[23] Lawrence Steinman,et al. Protein arrays for autoantibody profiling and fine‐specificity mapping , 2003, Proteomics.
[24] B. Seliger,et al. Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses. , 2003, Briefings in functional genomics & proteomics.
[25] A. Petersen. Two‐dimensional electrophoresis replica blotting: A valuable technique for the immunological and biochemical characterization of single components of complex extracts , 2003, Proteomics.
[26] J. Stulík,et al. Identification of new celiac disease autoantigens using proteomic analysis , 2003, Proteomics.
[27] B. Seliger,et al. Design of proteome‐based studies in combination with serology for the identification of biomarkers and novel targets , 2002, Proteomics.
[28] Gerd Ritter,et al. Immunotherapeutic Targets Cancer : Identification of Potential Diagnostic and Cancer-related Serological Recognition of Human Colon Updated , 2002 .
[29] E. Tan. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. , 2001, The Journal of clinical investigation.
[30] David E. Misek,et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] S. Hanash,et al. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. , 2001, Cancer research.
[32] R. G. Freeman,et al. Submicrometer metallic barcodes. , 2001, Science.
[33] S M Hanash,et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] K. Zatloukal,et al. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis , 2001, Proteomics.
[35] R. Roden,et al. A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Maisch,et al. Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two‐dimensional immunoblotting and N‐terminal sequence analysis , 2000, Clinical and experimental immunology.
[37] Dieter Stoll,et al. A microarray enzyme‐linked immunosorbent assay for autoimmune diagnostics , 2000, Electrophoresis.
[38] T. Soussi,et al. p53 Antibodies in the sera of patients with various types of cancer: a review. , 2000, Cancer research.
[39] P. Jungblut,et al. Toxoplasma gondii infection: analysis of serological response by 2-DE immunoblotting. , 1999, FEMS immunology and medical microbiology.
[40] R. Ward,et al. Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer. , 1999, Human immunology.
[41] H. Lehrach,et al. Protein microarrays for gene expression and antibody screening. , 1999, Analytical biochemistry.
[42] Yao-Tseng Chen,et al. Characterization of human colon cancer antigens recognized by autologous antibodies , 1998, International journal of cancer.
[43] Lloyd J. Old,et al. A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.
[44] Lloyd J. Old,et al. New Paths in Human Cancer Serology , 1998, The Journal of experimental medicine.
[45] K. Kaneko,et al. Identification and characterization of an anti-glial fibrillary acidic protein antibody with a unique specificity in a demented patient with an autoimmune disorder , 1997, Journal of the Neurological Sciences.
[46] L. Old,et al. Cancer Tumor antigens. , 1997, Current opinion in immunology.
[47] M. Pfreundschuh,et al. Serological identification of human tumor antigens. , 1997, Current opinion in immunology.
[48] E. Shimizu,et al. L-Myc overexpression and detection of auto-antibodies against L-Myc in both the serum and pleural effusion from a patient with non-small cell lung cancer. , 1997, Internal medicine.
[49] R J Fulton,et al. Advanced multiplexed analysis with the FlowMetrix system. , 1997, Clinical chemistry.
[50] S. Ménard,et al. 1975-1995 revised anti-cancer serological response: biological significance and clinical implications. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[51] M. Zweig,et al. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.
[52] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[53] L. Old,et al. Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics , 1977, The Journal of experimental medicine.